Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: A 10-year experience and reappraisal of its clinical utility

Gynecologic Oncology

Volumn 125, Issue 3, 2012, Pages 683-686

  Landon, G ^a   Stewart, J ^a   Deavers, M ^a   Lu, K ^a   Sneige, N ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

BRCA; Cytology; Occult ovarian carcinoma; Peritoneal washing; Salpingo oophorectomy

Indexed keywords

ANASTROZOLE; BRCA1 PROTEIN; BRCA2 PROTEIN; CARBOPLATIN; PACLITAXEL;

BENIGN TUMOR; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER SURGERY; CARCINOMATOUS PERITONITIS; CONFERENCE PAPER; CYSTADENOFIBROMA; CYTOPATHOLOGY; ENDOMETRIOSIS; ENDOSALPINGIOSIS; FIBROMA; FOLLOW UP; GENE MUTATION; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; LONG TERM CARE; MASTECTOMY; MULTIPLE CYCLE TREATMENT; OVARY; PERITONEUM LAVAGE; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; UTERINE TUBE;

FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; OVARIAN NEOPLASMS; OVARIECTOMY; PERITONEAL CAVITY; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84861193911     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.03.009     Document Type: Conference Paper

References (40)

1. S. Chen, and G. Parmigiani Meta-analysis of BRCA1 and BRCA2 penetrance J Clin Oncol 25 2007 1329 1333
2. D. Ford, D.F. Easton, M. Stratton, S. Narod, D. Goldgar, and P. Devilee Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 62 1998 676 689
3. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group Br J Cancer 83 2000 1301 1308
4. J.M. Satagopan, J. Boyd, N.D. Kauff, M. Robson, L. Scheuer, and S. Narod Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations Clin Cancer Res 8 2002 3776 3781
5. M.C. King, J.H. Marks, and J.B. Mandell Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 2003 643 646
6. J.P. Struewing, P. Hartge, S. Wacholder, S.M. Baker, M. Berlin, and M. McAdams The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews N Engl J Med 336 1997 1401 1408
7. NCCN Practice Guidelines in Oncology: Hereditary Breast and/or Ovarian Cancer 2011
8. T.R. Rebbeck, H.T. Lynch, S.L. Neuhausen, S.A. Narod, L. Van't Veer, and J.E. Garber Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 2002 1616 1622
9. A. Finch, M. Beiner, J. Lubinski, H.T. Lynch, P. Moller, and B. Rosen Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation JAMA 296 2006 185 192
10. M.S. Piver, M.F. Jishi, Y. Tsukada, and G. Nava Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry Cancer 71 1993 2751 2755
11. J.C. Pavelka, A.J. Li, and B.Y. Karlan Hereditary ovarian cancer - assessing risk and prevention strategies Obstet Gynecol Clin North Am 34 2007 651 665 vii-viii
12. Society of Gynecologic Oncologists Clinical Practice Committee Statement on Prophylactic Salpingo-oophorectomy Gynecol Oncol 98 2005 179 181
13. K.H. Lu, J.E. Garber, D.W. Cramer, W.R. Welch, J. Niloff, and D. Schrag Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy J Clin Oncol 18 2000 2728 2732
14. T.J. Colgan, S.L. Boerner, J. Murphy, D.E. Cole, S. Narod, and B. Rosen Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy Gynecol Oncol 85 2002 397 403
15. S.N. Agoff, R.L. Garcia, B. Goff, and E. Swisher Follow-up of in situ and early-stage fallopian tube carcinoma in patients undergoing prophylactic surgery for proven or suspected BRCA-1 or BRCA-2 mutations Am J Surg Pathol 28 2004 1112 1114
16. N.D. Kauff, and R.R. Barakat Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2 J Clin Oncol 25 2007 2921 2927
17. C.B. Powell, E. Kenley, L.M. Chen, B. Crawford, J. McLennan, and C. Zaloudek Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy J Clin Oncol 23 2005 127 132
18. S.N. Agoff, J.E. Mendelin, V.S. Grieco, and R.L. Garcia Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up Am J Surg Pathol 26 2002 171 178
19. K. Leeper, R. Garcia, E. Swisher, B. Goff, B. Greer, and P. Paley Pathologic findings in prophylactic oophorectomy specimens in high-risk women Gynecol Oncol 87 2002 52 56
20. D.A. Levine, P.A. Argenta, C.J. Yee, D.S. Marshall, N. Olvera, and F. Bogomolniy Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations J Clin Oncol 21 2003 4222 4227
21. J.L. Rutter, S. Wacholder, A. Chetrit, F. Lubin, J. Menczer, and S. Ebbers Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study J Natl Cancer Inst 95 2003 1072 1078
22. K. Leunen, E. Legius, P. Moerman, F. Amant, P. Neven, and I. Vergote Prophylactic salpingo-oophorectomy in 51 women with familial breast-ovarian cancer: importance of fallopian tube dysplasia Int J Gynecol Cancer 16 2006 183 188
23. F. Medeiros, M.G. Muto, Y. Lee, J.A. Elvin, M.J. Callahan, and C. Feltmate The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome Am J Surg Pathol 30 2006 230 236
24. C.P. Crum, R. Drapkin, D. Kindelberger, F. Medeiros, A. Miron, and Y. Lee Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer Clin Med Res 5 2007 35 44
25. S.M. Domchek, and T.R. Rebbeck Prophylactic oophorectomy in women at increased cancer risk Curr Opin Obstet Gynecol 19 2007 27 30
26. F. Laki, Y.M. Kirova, P. This, C. Plancher, B. Asselain, and X. Sastre Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation Cancer 109 2007 1784 1790
27. J.E. Hirst, G.B. Gard, K. McIllroy, D. Nevell, and M. Field High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy Int J Gynecol Cancer 19 2009 826 829
28. J.T. Rabban, M. Barnes, L.M. Chen, C.B. Powell, B. Crawford, and C.J. Zaloudek Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma Am J Surg Pathol 33 2009 1125 1136
29. K. Haldar, P. Giamougiannis, and R. Crawford Utility of peritoneal lavage cytology during laparoscopic salpingo-oophorectomy: a retrospective analysis BJOG 118 2010 28 33
30. P.J. Paley, E.M. Swisher, R.L. Garcia, S.N. Agoff, B.E. Greer, and K.L. Peters Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis Gynecol Oncol 80 2001 176 180
31. N. Sneige, and C.V. Fanning Peritoneal washing cytology in women: diagnostic pitfalls and clues for correct diagnosis Diagn Cytopathol 8 1992 632 640 discussion 640-2
32. N. Sneige, T. Fernandez, L.J. Copeland, and R.L. Katz Mullerian inclusions in peritoneal washings. Potential source of error in cytologic diagnosis Acta Cytol 30 1986 271 276
33. E.S. Cibas, and B.S. Ducatman Cytology: diagnostic principles and clinical correlates 3rd ed. 2009 Elsevier (Saunders)
34. Y. Lee, F. Medeiros, D. Kindelberger, M.J. Callahan, M.G. Muto, and C.P. Crum Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer Adv Anat Pathol 13 2006 1 7
35. B.A. Clark, C.P. Crum, M.R. Nucci, E. Oliva, and K. Cooper College of American Pathologists Cancer Protocols and Checklists: Protocol for the Examination of Specimens from Patients with Carcinoma of the Fallopian Tube 2011 1 17
36. R.E. Zuna, and M.L. Mitchell Cytologic findings in peritoneal washings associated with benign gynecologic disease Acta Cytol 32 1988 139 147
37. R.E. Zuna, M.L. Mitchell, K.A. Mulick, and W.M. Weijchert Cytohistologic correlation of peritoneal washing cytology in gynecologic disease Acta Cytol 33 1989 327 336
38. E.M. Wojcik, and B. Naylor "Collagen balls" in peritoneal washings. Prevalence, morphology, origin and significance Acta Cytol 36 1992 466 470
39. Y. Sonoda, M. Zerbe, A. Smith, O. Lin, R.R. Barakat, and W.J. Hoskins High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy Gynecol Oncol 80 2001 378 382
40. P.A. Shaw, M. Rouzbahman, E.S. Pizer, M. Pintilie, and H. Begley Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers Mod Pathol 22 2009 1133 1138